Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
- PROFIT & LOSS
- BALANCE SHEET
- RETURN CALCULATOR
- CORPORATE ACTION
- SHAREHOLDING PATTERN
- QUARTERLY RESULT
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Operating Income | 0.95 | 0.11 | 0 | 0 | 0 |
| Other Income | 0 | 0.05 | 0 | 0 | 0 |
| Total Income | 0.95 | 0.16 | 0 | 0 | 0 |
| EXPENDITURE : | |||||
| Interest and Financial Charges | 0 | 0 | 0 | 0 | 0 |
| Operating and Administrative Expenses | 0.95 | 6.72 | 0.12 | 0.02 | 0.04 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Depreciation and Tax | 0 | -6.56 | -0.12 | -0.03 | -0.04 |
| Depreciation | 0 | 0 | 0 | 0 | 0.1 |
| Profit Before Tax | 0 | -6.56 | -0.12 | -0.03 | -0.13 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | -6.56 | -0.12 | -0.03 | -0.13 |
| Adjustment below net profit | 0 | 0 | 0 | 0 | 0 |
| P and L Balance brought forward | -10.98 | -4.42 | -4.3 | -4.27 | -4.14 |
| Appropriations | 0 | 0 | 0 | 0 | 0 |
| P and L Balance carried down | -10.99 | -10.98 | -4.42 | -4.3 | -4.27 |
| Equity Dividend | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 0 | 0 | 0 | 0 | 0 |
| Book Value | 0.83 | 0.83 | 0.93 | 0.93 | 0.93 |
| Extraordinary Items | 0 | 0 | 0 | 0 | 0 |
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 |
| Reserves and Surplus | -10.99 | -10.98 | -4.42 | -4.3 | -4.27 |
| Total Shareholders Funds | 54.27 | 54.28 | 60.84 | 60.96 | 60.99 |
| Secured Loans | 0 | 0 | 0 | 0 | 0 |
| Unsecured Loans | 0.63 | 0.01 | 0.72 | 6.21 | 10 |
| Total Debt | 0.63 | 0.01 | 0.72 | 6.21 | 10 |
| Total Liabilities | 54.9 | 54.29 | 61.56 | 67.17 | 70.99 |
| APPLICATION OF FUNDS : | |||||
| Fixed Assets | |||||
| Gross Block | 0 | 0 | 0 | 0 | 0 |
| Less: Accumulated Depreciation | 0 | 0 | 0 | 0 | 0 |
| Net Block | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 4.65 | 3.52 | 22.39 | 26.69 | 43.78 |
| Current Assts.,Loans and Advances | |||||
| Current Assets | 8.03 | 7.05 | 0.06 | 0.13 | 0.96 |
| Loans and Advances | 44.95 | 45.36 | 40.79 | 41.98 | 28.75 |
| Less: Current Liabilities and Provisions | 2.73 | 1.64 | 1.69 | 1.64 | 2.5 |
| Net Current Assets | 50.25 | 50.77 | 39.16 | 40.47 | 27.21 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 54.9 | 54.29 | 61.55 | 67.16 | 70.99 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
If I had made LUMPSUM investment of ₹ 1,00,000
in Biogen Pharma
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
